LONDON — The World Health Organization said that it will temporarily drop hydroxychloroquine — the malaria drug U.S. President Trump has said he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.
In a news briefing on Monday, WHO director-general Tedros Adhanom Ghebreyesus said that in light of a paper published last week in the Lancet, that found people taking hydroxychloroquine were at higher risk of death and heart problems than those that were not, there would be “a temporary pause” on the hydroxychloroquine arm of its global clinical trial.
“This concern relates to the use of hydroxychloroquine and chloroquine in COVID-19,” Tedros said, adding that the drugs remain, as has been the case for decades, accepted treatments for people with malaria or autoimmune diseases. Other treatments in the study, including the experimental drug remdesivir and an HIV combination therapy, are still being pursued.
Read on:Moderna’s stock soars then dips after questions arise around the limited data shared about its COVID-19 vaccine
After trump air them out huh smfh. They want new drugs to make more money from it. KillGates ObamaGates
WHO, Grow up, Don't drop HCQ from the study just because you hate Trump.Many patients taking it improved in 2 days.Yes it does have many side effects but when you're desperate you try it. It has anti inflammatory properties. If good for Lupus and arthritis, maybe also for Covid19
Wonder if this was why Trump couldn’t stand straight today and sounded like he was drunk....
Dow to 30000
The same WHO that lied to us about China and their Transparency? 🖕 So now we should care what they have to say?
I wonder why ?
But keep taking them, realDonaldTrump! 👍🏻
Now let’s “suspend “. Trump VoteBlueToSaveAmerica2020
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: HuffPostWomen - 🏆 27. / 68 Read more »
Source: latimes - 🏆 11. / 82 Read more »
Source: politico - 🏆 381. / 59 Read more »
Source: NPR - 🏆 96. / 63 Read more »
Source: THR - 🏆 411. / 53 Read more »
Source: WSJ - 🏆 98. / 63 Read more »